Cargando…
Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer
Breast cancer remains a major cause of death among women. 15% of these cancers are triple negative breast cancer (TNBC), an aggressive subtype of breast cancer for which no current effective targeted therapy exists. We have previously demonstrated a role for mGluR1 in mediating tumor cell growth, en...
Autores principales: | Sexton, Rachel E., Hachem, Ali H., Assi, Ali A., Bukhsh, Miriam A., Gorski, David H., Speyer, Cecilia L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207734/ https://www.ncbi.nlm.nih.gov/pubmed/30375476 http://dx.doi.org/10.1038/s41598-018-34502-8 |
Ejemplares similares
-
Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast Cancer
por: Speyer, Cecilia L., et al.
Publicado: (2014) -
Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer
por: Banda, Malathi, et al.
Publicado: (2014) -
Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020) -
Metabotropic Glutamate Receptor Subtype 5 in Alcohol-Induced Negative Affect
por: Kasten, Chelsea R., et al.
Publicado: (2019) -
Metabotropic glutamate receptors inhibit microglial glutamate release
por: McMullan, Stephen M, et al.
Publicado: (2012)